Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior

被引:199
作者
Heinrichs, SC
Lapsansky, J
Lovenberg, TW
DeSouza, EB
Chalmers, DT
机构
[1] Neurocrine Biosciences, Inc., San Diego, CA 92121
关键词
plus maze; defensive withdrawal; oligonucleotide; adrenocorticotropic hormone; swim stressor; body weight;
D O I
10.1016/S0167-0115(97)01005-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The recent identification and differential localization in brain of three binding sites for corticotropin-releasing factor (CRF)-like peptides (CRF1 and CRF2 receptors as well as CRF-binding protein) suggest the existence of functionally distinct neurobiological systems which mediate CRF activation. For instance, evidence from receptor knockdown and pharmacological studies suggests involvement of the CRF1 receptor in anxiogenic-like behavior and the CRF-binding protein in learning and memory processes. The present studies examined the potential functional significance of the CRF2 receptor in relation to the CRF1 receptor using two animal models of anxiety and endocrine reactivity to a stressor. CRF1 and CRF2 receptor knockdown was achieved and confirmed autoradiographically within brain regions relevant to behavioral reactivity to stressors by chronic, central administration of antisense oligonucleotides. CRF1, but not CRF2, knockdown produced a significant anxiolytic-like effect in the Defensive Withdrawal paradigm relative to vehicle-treated and two missense oligonucleotide negative control groups. In contrast, neither antisense treatment altered endocrine or behavioral reactivity to a swim stressor. Thus, the present data support the reported role of CRF1 receptors in the mediation of anxiogenic-like behavior and suggest a functionally distinct role for CRF2 receptors in brain. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:15 / 21
页数:7
相关论文
共 21 条
  • [1] A DECREASE IN ANGIOTENSIN RECEPTOR-BINDING IN RAT-BRAIN NUCLEI BY ANTISENSE OLIGONUCLEOTIDES TO THE ANGIOTENSIN AT(1) RECEPTOR
    AMBUHL, P
    GYURKO, R
    PHILLIPS, MI
    [J]. REGULATORY PEPTIDES, 1995, 59 (02) : 171 - 182
  • [2] DISPLACEMENT OF CORTICOTROPIN-RELEASING FACTOR FROM ITS BINDING-PROTEIN AS A POSSIBLE TREATMENT FOR ALZHEIMERS-DISEASE
    BEHAN, DP
    HEINRICHS, SC
    TRONCOSO, JC
    LIU, XJ
    KAWAS, CH
    LING, N
    DESOUZA, EB
    [J]. NATURE, 1995, 378 (6554) : 284 - 287
  • [3] PREGNANE STEROID ALPHAXALONE ATTENUATES ANXIOGENIC BEHAVIORAL-EFFECTS OF CORTICOTROPIN RELEASING-FACTOR AND STRESS
    BRITTON, KT
    MCLEOD, S
    KOOB, GF
    HAUGER, R
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1992, 41 (02) : 399 - 403
  • [4] Corticotrophin-releasing factor receptors: From molecular biology to drug design
    Chalmers, DT
    Lovenberg, TW
    Grigoriadis, DE
    Behan, DP
    DeSouza, EB
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1996, 17 (04) : 166 - 172
  • [5] CHALMERS DT, 1995, J NEUROSCI, V15, P6340
  • [6] Chen C, 1996, J MED CHEM, V39, P4358
  • [7] deFonseca FR, 1996, J PHARMACOL EXP THER, V276, P56
  • [8] DESOUZA EB, 1985, J NEUROSCI, V5, P3189
  • [9] Grigoriadis DE, 1996, MOL PHARMACOL, V50, P679
  • [10] ANTISTRESS ACTION OF A CORTICOTROPIN-RELEASING FACTOR ANTAGONIST ON BEHAVIORAL REACTIVITY TO STRESSORS OF VARYING TYPE AND INTENSITY
    HEINRICHS, SC
    MENZAGHI, F
    PICH, EM
    BALDWIN, HA
    RASSNICK, S
    BRITTON, KT
    KOOB, GF
    [J]. NEUROPSYCHOPHARMACOLOGY, 1994, 11 (03) : 179 - 186